



































































Correction to: Casper Versus Precise Stent for the Treatment of Patients
with Idiopathic Intracranial Hypertension
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After the article was published online, the abstract was re-
vised again. The correct abstract is given below. The origi-
nal article has been corrected.
Abstract
Purpose We hypothesized that due to its specific character-
istics, the CasperTM RX carotid stent (CP) might be partic-
ularly suitable for venous sinus stenting (VSS) in patients
with idiopathic intracranial hypertension (IIH). To test this
theory, we compared it to the commonly used Precise Pro
RXTM stent (PP).
The online version of the original article can be found under
https://doi.org/10.1007/s00062-021-01024-2.
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Methods A total of 15 patients with IIH (median age
28.7 years) were reviewed retrospectively. Technical as-
pects as well as peri- and postinterventional complication
rates were examined in patients treated with CP (n= 10)
and the PP (n= 5). Improvements in cerebrospinal fluid
opening pressure (CSF OP), transstenotic pressure gradient
(TSPG) and clinical symptoms were also assessed.
Results Stent delivery was easier and more successful with
the CP than the PP (difficult/failed stent delivery 0.0% ver-
sus 57.1%) and consequently achieved with less attempts
(≥2: 0.0% versus 40.0%). No severe peri- or postinter-
ventional complications or instances of in-stent thrombosis
and/or stenosis were observed during follow-up. Improve-
ment of CSF OP and TSPG immediately after VSS as well
as at 6-month follow-up was comparable between the CP
and PP group. Both groups showed substantial and similar
decreases in intensity and frequency of headache. Almost
all patients with other IIH-related symptoms showed either
improvement or complete resolution of those symptoms
after VSS. All patients who were available for interview
(n= 12/15) reported a substantial improvement in quality of
life.
Conclusion VSS using the CP seems to be safe and effec-
tive. The CP may reduce the risk of difficult or failed stent
delivery in patients with challenging intracranial venous
anatomy.
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Open Access This article is licensed under a Creative Commons At-
tribution 4.0 International License, which permits use, sharing, adapta-
tion, distribution and reproduction in any medium or format, as long as
you give appropriate credit to the original author(s) and the source, pro-
vide a link to the Creative Commons licence, and indicate if changes
were made. The images or other third party material in this article are
included in the article’s Creative Commons licence, unless indicated
otherwise in a credit line to the material. If material is not included
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in the article’s Creative Commons licence and your intended use is not
permitted by statutory regulation or exceeds the permitted use, you will
need to obtain permission directly from the copyright holder. To view
a copy of this licence, visit http://creativecommons.org/licenses/by/4.
0/.
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